Bioventix PLC (AIM:BVXP)
London
· Delayed Price · Currency is GBP · Price in GBX 1,650.00
-50.00 (-2.94%)
Apr 28, 2026, 5:15 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 88.82 million as of April 28, 2026. Its market cap has decreased by -30.54% in one year.
Market Cap
88.82M
Enterprise Value
83.52M
Revenue
12.54M
Ranking
n/a
PE Ratio
12.10
Stock Price
1,650.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 88.82M, an increase of 801.98%. That is a compound annual growth rate of 14.67%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 83.80M |
| 4basebio | 78.16M |
| Ondine Biomedical | 64.94M |
| Scancell Holdings | 134.91M |
| Hemogenyx Pharmaceuticals | 51.60M |
| hVIVO | 50.50M |
| Poolbeg Pharma | 31.38M |
| Sareum Holdings | 28.99M |